drugset / Trial / NCT00816673

Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs

NCT00816673

Phase 2 Completed 40 enrolled Neurim Pharmaceuticals Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this placebo controlled study is to investigate the effect of 2 mg melatonin Slow Release (Circadin®) on the sleep/wake cycle in elderly insomniac out-subjects, aged 55 years or more.

Timeline

Start
1996-09
Primary completion
1997-05
Completion
1997-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 2 mg

Indications